Product Introduction
Glimestar PM 3/500/15 mg Tablet is a triple combination of Glimepiride, Metformin, and Pioglitazone, designed for managing type 2 diabetes mellitus. It helps in improving insulin sensitivity, reducing hepatic glucose production, and stimulating insulin release from the pancreas. It is generally prescribed when monotherapy or dual therapy is insufficient.
Uses of Glimestar PM Tablet
-
Management of type 2 diabetes mellitus
-
Controls high blood sugar levels
-
Prevents diabetes-related complications
Benefits of Glimestar PM Tablet
-
Helps in achieving better blood glucose control
-
Reduces insulin resistance
-
Enhances pancreatic insulin release
-
May lower the risk of long-term diabetes complications
Composition
-
Glimepiride 3 mg – A sulfonylurea that increases insulin secretion
-
Metformin 500 mg – A biguanide that decreases glucose production in the liver
-
Pioglitazone 15 mg – A thiazolidinedione that improves insulin sensitivity
Side Effects
-
Hypoglycemia (low blood sugar)
-
Nausea or upset stomach
-
Weight gain
-
Edema (swelling)
-
Headache
-
Muscle pain
-
Risk of lactic acidosis (rare, but serious – due to Metformin)
Safety Advice
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood sugar regularly
-
Avoid alcohol as it increases the risk of lactic acidosis and hypoglycemia
-
Use with caution in patients with heart, liver, or kidney conditions
-
Not recommended during pregnancy or breastfeeding unless prescribed
-
Regular monitoring of blood parameters advised (liver, kidney, blood sugar)
-
Store in a cool, dry place; keep out of reach of children
